title: Alterations of O-glycan biosynthesis in human colon cancer tissues.
abstract: Human colon cancer is associated with antigenic and structural changes in mucin-type carbohydrate chains (O-glycans). To elucidate the control of the biosynthesis of these O-glycans is colon cancer, we have studied glycosyltransferase and sulphotransferase activities involved in the assembly of elongated O-glycan structures. We analysed homogenates prepared from cancer tissue, adjacent normal and distal normal tissue from 20 patients. Several transferase activities showed pronounced changes in cancer tissue. The changes correlate with previous findings of a loss of O-glycans in cancer mucins, but did not always correlate with levels of Tn, sialyl-Tn, T and Lex antigens in homogenates or with the differentiation status and Duke's stages of the cancer tissue or the patient's blood type, sex and age. UDP-GlcNAc: Gal NAc-R beta 3-N-acetylglucosaminyltransferase (where GlcNAc is N-acetyl-D-glucosamine and GalNAc is N-acetyl-D-galactosamine) synthesizing O-glycan core 3, GlcNAc beta 1-3GalNAc-, CMP-sialic acid: GalNAc-peptide alpha 6-sialyltransferase synthesizing the sialyl-Tn antigen and sulphotransferase activities towards O-glycan core 1, Gal beta 1-3GalNAc-, were found to be decreased in cancer. UDP-GlcNAc: Gal beta 1-3GalNAc beta 6-N-acetylglucosaminyltransferase was also decreased in cancer concomitant with a loss of the ability to synthesize the I antigen and core 4, GlcNAc beta 1-6(GlcNAc beta 1-3) GalNAc-, CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase and GDP-fucose: Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue. The data suggest that the biosynthesis of antigens and mucin-bound O-glycan structures in colon cancer is subject to complex control mechanisms.
authors.affiliation: Department of Biochemistry, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: J M
authors.initials: JM
authors.lastname: Yang
authors.forename: J C
authors.initials: JC
authors.lastname: Byrd
authors.forename: B B
authors.initials: BB
authors.lastname: Siddiki
authors.forename: Y S
authors.initials: YS
authors.lastname: Chung
authors.forename: M
authors.initials: M
authors.lastname: Okuno
authors.forename: M
authors.initials: M
authors.lastname: Sowa
authors.forename: Y S
authors.initials: YS
authors.lastname: Kim
authors.forename: K L
authors.initials: KL
authors.lastname: Matta
authors.forename: I
authors.initials: I
authors.lastname: Brockhausen
mesh_terms: D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000096:biosynthesis / Q000737:chemistry; D002240:Carbohydrate Sequence; D003110:Colonic Neoplasms / Q000276:immunology / Q000378:metabolism*; D005260:Female; D005643:Fucose / Q000737:chemistry; D016695:Glycosyltransferases / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D017351:N-Acetylglucosaminyltransferases / Q000378:metabolism; D010455:Peptides / Q000737:chemistry; D011134:Polysaccharides / Q000096:biosynthesis* / Q000737:chemistry; D012799:Sialyltransferases / Q000378:metabolism; D013379:Substrate Specificity; D015238:Sulfotransferases / Q000378:metabolism
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D010455:Peptides; D011134:Polysaccharides; D005643:Fucose; D016695:Glycosyltransferases; D017351:N-Acetylglucosaminyltransferases; D012799:Sialyltransferases; D015238:Sulfotransferases